Overview
- The Indian drugmaker said it will invest $250 million over five years covering research and development, infrastructure and capital expenditures.
- The Coral Springs facility is designed to produce more than 25 respiratory medicines, including albuterol inhalers for children with asthma and U.S. service members.
- Lupin acquired more than five acres for a roughly 70,000-square-foot expansion, with construction projected to employ over 1,000 workers, according to local reporting.
- The project is expected to create over 200 long-term skilled jobs in Broward County by 2030, with Florida pledging tax credits and other incentives for the investment.
- Shares rose about 3% in early trading on Indian exchanges following the announcement, reflecting a positive investor reaction.